Trade PTCT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
PTC Therapeutics, Inc. (PTCT) is trading at US$65.37, down 3.87% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$5.83B. Over the past 52 weeks, PTCT has traded between US$57.74 and US$90.87. On Syfe you can trade PTCT with $0 commission and add it to your watchlist.
| Previous close | US$68.00 |
|---|---|
| Market cap | US$5.83B |
| P/E ratio | 28.28 |
| 52-week range | US$57.74 – US$90.87 |
| Volume | 3.67M |
| Exchange | US |
Add to Watchlist
Set Price Alert
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Year: 2013
PTC Q2 Swings to Profit, Revenue Rises; Ups Guidance
Jul 30, 8:46 PM · MT Newswires
--GUIDANCE: (PTCT) PTC Therapeutics Expects Full Year 2026 Revenue Range $1.18B - $1.28B, vs. FactSet Est of $1.18B
Jul 30, 8:34 PM · MT Newswires
-- Earnings Flash (PTCT) PTC Therapeutics Posts Q2 EPS $0.92, vs. FactSet Est of $0.24
Jul 30, 8:30 PM · MT Newswires
-- Earnings Flash (PTCT) PTC Therapeutics, Inc. Reports Q2 Revenue $360.5M, vs. FactSet Est of $298.6M
Jul 30, 8:06 PM · MT Newswires
PTC Therapeutics' Phenylketonuria Physician Survey Yielded Mixed Results on Sephience Launch Momentum, RBC Says
Jul 27, 3:37 PM · MT Newswires
PTC Therapeutics, Inc. (PTCT) stock is trading at US$65.37, -3.87% from the previous close of US$68.00.
The market cap for PTC Therapeutics, Inc. (PTCT) stock is approximately US$5.83B.
The price-to-earnings ratio for PTC Therapeutics, Inc. (PTCT) is 28.28, based on the latest reported earnings.
The 52-week high for PTC Therapeutics, Inc. (PTCT) stock is US$90.87.
The 52-week low for PTC Therapeutics, Inc. (PTCT) stock is US$57.74.
PTC Therapeutics, Inc. (PTCT) does not currently pay a dividend.
Stay on top of PTCT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore